Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

BACKGROUND: Recurrence of prior invasive fungal infection (relapse rate of 30–50%) limits the success of stem cell transplantation. Secondary prophylaxis could reduce disease burden and improve survival. DESIGN AND METHODS: A prospective, open-label, multicenter trial was conducted evaluating vorico...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cordonnier, Catherine, Rovira, Montserrat, Maertens, Johan, Olavarria, Eduardo, Faucher, Catherine, Bilger, Karin, Pigneux, Arnaud, Cornely, Oliver A, Ullmann, Andrew J., Bofarull, Rodrigo Martino, de la Cámara, Rafael, Weisser, Maja, Liakopoulou, Effie, Abecasis, Manuel, Heussel, Claus Peter, Pineau, Marc, Ljungman, Per, Einsele, Hermann
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948103/
https://ncbi.nlm.nih.gov/pubmed/20634495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.020073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados